Revance Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $337k | 38k | 8.79 |
| 2023-09-30 | $405k | 35k | 11.47 |
| 2023-06-30 | $1.8M | 72k | 25.31 |
| 2022-12-31 | $1.6M | 84k | 18.46 |
| 2022-09-30 | $2.5M | 93k | 27.27 |
| 2022-06-30 | $1.3M | 92k | 13.93 |
| 2022-03-31 | $2.0M | 103k | 19.54 |
| 2021-12-31 | $3.2M | 170k | 18.63 |
| 2021-09-30 | $14M | 493k | 27.94 |
| 2021-06-30 | $12M | 407k | 29.67 |
| 2021-03-31 | $12M | 420k | 27.95 |
| 2020-12-31 | $12M | 430k | 28.34 |
| 2020-09-30 | $6.3M | 252k | 25.14 |
| 2020-06-30 | $1.9M | 78k | 24.43 |
| 2020-03-31 | $837k | 57k | 14.79 |
| 2019-12-31 | $729k | 45k | 16.23 |
| 2019-09-30 | $369k | 28k | 12.98 |
| 2019-06-30 | $346k | 27k | 12.95 |
| 2019-03-31 | $313k | 20k | 15.76 |
| 2018-12-31 | $366k | 18k | 20.12 |
| 2018-09-30 | $390k | 16k | 24.85 |
| 2018-06-30 | $398k | 15k | 27.46 |
| 2018-03-31 | $789k | 26k | 30.79 |
| 2017-12-31 | $499k | 14k | 35.78 |
| 2017-06-30 | $615k | 23k | 26.39 |
| 2017-03-31 | $1.5M | 71k | 20.78 |
| 2016-12-31 | $1.8M | 86k | 20.71 |
| 2016-09-30 | $178k | 11k | 16.21 |
| 2016-06-30 | $126k | 9.2k | 13.60 |
| 2016-03-31 | $183k | 11k | 17.36 |
| 2015-12-31 | $252k | 7.4k | 34.10 |
| 2015-09-30 | $260k | 8.8k | 29.70 |
| 2015-03-31 | $96k | 4.7k | 20.41 |
| 2014-12-31 | $32k | 1.8k | 17.54 |
| 2014-06-30 | $39k | 1.1k | 34.55 |